鹽酸西替利嗪市場：按劑型、年齡層、應用、通路和地區分類

Cetirizine Hydrochloride Market, By Dosage Form, By Age Group, By Application, By Distribution Channel, By Geography

出版日期: 2026年05月29日 | 出版商:

Coherent Market Insights | 英文 258 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年鹽酸西替利嗪市場規模估計為24億美元，預計2033年將達39億美元。預計2026年至2033年，其複合年成長率將達7.2%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	24億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.20%	2033年市場規模預測：	39億美元

鹽酸西替利嗪是第二代組織胺H1受體拮抗劑，可有效治療過敏性鼻炎、慢性蕁麻疹和花粉誘發氣喘。與傳統抗組織胺藥物不同，西替利嗪不會引起嗜睡或抗膽鹼能副作用。西替利嗪有多種劑型，包括片劑、咀嚼片、膠囊和液體。

市場動態

兒童和成人過敏性疾病盛行率的不斷上升是鹽酸西替利嗪市場成長的主要促進因素。根據2014年美國國家健康調查（NHIS）的數據，美國18歲以下兒童中約有8.4%患有花粉症，10%患有呼吸道過敏，5.4%患有食物過敏，11.6%患有皮膚過敏。此外，過敏性結膜炎給患者帶來沉重的經濟和社會負擔，導致人們對有效治療方法的需求日益成長，以遏制不斷上漲的醫療保健成本。根據威斯康辛大學眼科和視覺科學系（2013年）估計，美國每年約有600萬人患有細菌性結膜炎。據報道，治療該疾病的總費用每年在3.77億美元至8.57億美元之間。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球鹽酸西替利嗪市場的主要參與者進行了分析：公司概況、財務表現、產品系列、市場地位、分銷策略、主要發展、策略和未來計劃。
透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份「全球鹽酸西替利嗪市場報告」旨在為該行業的各種相關人員提供服務，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析鹽酸西替利嗪市場中使用的各種策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Johnson and Johnson
- Mylan, Inc.
- Nicox SA
- Strides Shasun
- Apotex, Inc.
- Teva UK Limited
- Aurobindo Pharma Limited
- Jubiliant Life Sciences
- Tris Pharma, Inc.
- Cipla Ltd.

第10章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI2069

Cetirizine Hydrochloride Market is estimated to be valued at USD 2.4 Bn in 2026 and is expected to reach USD 3.9 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.4 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.20%	2033 Value Projection:	USD 3.9 Bn

Cetirizine hydrochloride is a second-generation histamine H1 antagonist that is effective in treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Cetirizine does not cause drowsiness or anticholinergic side effects opposed to conventional antihistamines. Cetirizine is available in various forms such as regular and chewable tablets, capsules, and solutions.

Market Dynamics

Increasing prevalence of allergic conditions in children and adult population is major factor driving growth of the cetirizine hydrochloride market. According to the National Health Interview Survey (NHIS), 2014, around 8.4% of children under the age of 18 suffered from hay fever, 10% from respiratory allergies, 5.4% from food allergies, and 11.6% from skin allergies in the U.S. Furthermore, allergic conjunctivitis imposes economic and social burden on the affected population, thereby increasing the adoption of efficient treatment to curb the increasing healthcare costs. According to the Department of Ophthalmology and Visual Sciences, University of Wisconsin, 2013, an estimated 6 million people are affected by bacterial conjunctivitis, annually in the U.S. The total expenditure in treatment of the disease was reported around US $377 million to US$ 857 million, annually.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global cetirizine hydrochloride market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Johnson and Johnson, Mylan, Inc., Nicox S.A., Strides Shasun, Apotex, Inc., Teva UK Limited, Aurobindo Pharma Limited, Jubilant Life Sciences, Tris Pharma, Inc., and Cipla Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global cetirizine hydrochloride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cetirizine hydrochloride market

Market Segmentation

By Dosage Form (Revenue, USD Bn, 2021-2033)
- Tablet
- Syrup
- Solution
By Age Group (Revenue, USD Bn, 2021-2033)
- Adult
- Pediatric
By Application (Revenue, USD Bn, 2021-2033)
- Allergic Rhinitis
- Allergic Conjunctivitis
- Eczema
- Others
By Distribution Channel (Revenue, USD Bn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- Johnson and Johnson
- Mylan, Inc.
- Nicox S.A.
- Strides Shasun
- Apotex, Inc.
- Teva UK Limited
- Aurobindo Pharma Limited
- Jubilant Life Sciences
- Tris Pharma, Inc.
- Cipla Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Dosage Form
- Market Snapshot, By Age Group
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Cetirizine Hydrochloride Market, By Dosage Form, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Tablet
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Syrup
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Cetirizine Hydrochloride Market, By Age Group, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Cetirizine Hydrochloride Market, By Application, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Allergic Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Eczema
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Global Cetirizine Hydrochloride Market, By Distribution Channel, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

8. Global Cetirizine Hydrochloride Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Johnson and Johnson
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Mylan, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Nicox S.A.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Strides Shasun
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Apotex, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Teva UK Limited
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Aurobindo Pharma Limited
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Jubiliant Life Sciences
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Tris Pharma, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Cipla Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
  - Analyst Views